Announcements Trials
Browse Landscape

Status

Completed 5Unknown 1Active not recruiting 1

Sponsor Class

OTHER 10INDUSTRY 7OTHER_GOV 1

Study Type

Interventional 104Observational 7Expanded_access 1

Sponsor

Cancer Type

Thoracic 7

Conditions

Carcinoma, Non-Small-Cell Lung 6T790M Positive NSCLC Patients 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Observational × osimertinib × Clear all
NCT05103605 2025-12-01

POSITHES

AstraZeneca

Active not recruiting
274 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05834348 2025-03-30

DELINOR

Pfizer

Completed
5,279 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04179890 2023-05-25

UpSwinG

Boehringer Ingelheim

Completed
462 enrolled 23 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05513664 2022-08-24

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Shanghai JMT-Bio Inc.

Unknown
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03219970 2021-09-14

Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.

AstraZeneca

Completed
156 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03370770 2020-12-24

Afatinib Osimertinib Sequencing NIS

Boehringer Ingelheim

Completed
204 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03133234 2018-11-20

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

AstraZeneca

Completed
47 enrolled
Thoracic

T790M Positive NSCLC Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡